Immunization and immunotherapy for mastitis

Subclinical mastitis in dairy cows in major milk-producing areas of Sri Lanka: Prevalence, associated risk factors, and effects on reproduction

Compared with clinical mastitis, the subclinical form of mastitis (SCM) is more common and thought to cause more economic losses to the dairy industry. The current study aimed to investigate the prevalence, risk factors of SCM, and effects on reproduction of dairy cows in major milk-producing areas of Sri Lanka. A total of 1,357 cows of selected farms in 3 regions were examined in the study. California Mastitis Test was conducted for individual cows, and a score of 2 or more for any quarter without any clinical symptoms and abnormalities in milk was considered as positive for SCM. Samples from infected animals were collected and subjected to bacteriological analysis. A pretested questionnaire was used to collect data on individual cows and herds. Risk factors associated with SCM were analyzed using binary logistic regression in generalized linear mixed models. The effect of SCM on calving to conception interval and days from calving to artificial insemination were analyzed by survival analysis using Cox's proportional hazards regression and Kaplan-Meier survival function estimates, respectively. A Poisson regression model was run to determine the effect of SCM on number of artificial inseminations per conception. The prevalence of SCM was 57.5, 11.8, and 45.5% in the regions A, B, and C, respectively. The most common pathogen was Staphylococcus aureus, with 87.1, 56.5, and 92.3% in the regions A, B, and C, respectively. Logistic regression analysis showed that parity, farming system, milking area, region, and herd significantly affect the prevalence of SCM. Subclinical mastitis during the pre-breeding period was associated with 14% increase in the chance of having a greater number of artificial inseminations per conception. Likewise, median days from calving to artificial insemination was longer in cows with SCM compared with normal cows (79 and 64 d, respectively). Therefore, SCM affected the inseminated proportion of studied cows. However, SCM was not associated with the calving to conception interval. The results revealed that the cow factors and milk hygiene play a significant role in the prevalence of SCM.

Bovine mastitis and intramammary drug delivery: review and perspectives

Intramammary infections (IMIs) represent a major feature in bovine pathology. The treatment of IMIs concern antimicrobial substances. Therapeutic strategies involve administration of immediate release formulations during lactation with or without long-acting formulations during the dry period. Current treatments are not very successful and cure rates are poor, especially towards Staphylococcus aureus which is responsible for chronic infections and huge economic losses. New strategies have recently been investigated. These include particular immunomodulators like lysostaphin or cytokines, and novel formulations (e.g. liposomes, microparticles or nanoparticles) that allow uptake of the active component by phagocytes and thus prolong an enhanced antibacterial activity.

Study on risk factors and their association with subclinical mastitis in lactating dairy cows in Trinidad

A cross-sectional study was conducted on dairy farms in eight milking centres in Trinidad to determine the prevalence of risk factors for mastitis and to assess their relationship to occurrence of subclinical mastitis. The California mastitis test (CMT) was used to determine the prevalence of subclinical mastitis by estimating the somatic cell counts in bulk and composite milk. Of a total of 177 dairy farms studied, 121 (68.4%), 39 (22.0%) and 17 (9.6%) practised semi-intensive, extensive and intensive management systems, respectively. A total of 129 (72.9%), 37 (20.9%) and 11 (6.2%) farms milked cows in parlours, stanchions and pasture/out-on-field, respectively. Based on sanitary practices, 40 (22.6%), 123 (69.5%), and 14 (7.9%) farms were classified as good, fair, and poor, respectively, while 76 (42.9%) and 60 (33.9%) farms reported to rarely experience and frequently experience water shortages, respectively. Amongst the 177 farms, only seven (4.0%) used machine-milking primarily, 152 (85.9%) screened for mastitis as a routine, 18 (10.2%) teat dipped, and 49 (27.7%) practised dry cow therapy. To detect mastitis, of 152 farms involved, 20 (13.2%) used the strip cup while only two (1.3%) employed the CMT. Pipe-borne water delivered directly from the hose was the only source of water to 91 (51.4%) farms while seven (4.0%) and eight (4.5%) farms used only well and surface water (ponds and rivers), respectively. Based on bulk milk samples, the farm prevalence of subclinical mastitis was 60.5% (107 of 177) with a range from 33.3% (centre 5H) to 100.0% (centre 2B). The difference was statistically significant (P < 0.01; chi 2). However, using composite milk, the farm prevalence of subclinical mastitis was 52.5% (93 of 177) with a range from 21.2% (centre 5H) to 92.9% (centre 2B) and again, the difference in prevalence was statistically significant (P < 0.001; chi 2). Subclinical mastitis was detected in 150 (45.0%) of 333 lactating cows screened and the range of prevalence was from 17.9% (centre 5H) to 56.3% (centre 1C). The difference was statistically significant (P < 0.001; chi 2). Of a total of 14 risk factors for mastitis studied which were related to animal husbandry, personnel, mastitis control and water, only two, the herd size and practice of dry cow therapy were significantly (P < 0.05; chi 2) associated with subclinical mastitis. It was concluded that the high prevalence of subclinical mastitis in Trinidad dairy herds could significantly reduce milk production with associated economic loss. Although a majority of the risk factors studied were not found to be significantly associated with the occurrence of subclinical mastitis possibly due to confounding factors, the need to eliminate or reduce these risk factors cannot be over-emphasized.

Efficacy of a Propionibacterium acnes immunostimulant for treatment of chronic Staphylococcus aureus mastitis

This study determined the efficacy of treatment of chronic Staphylococcus aureus IMI of lactating dairy cows with a biological response modifier consisting of a killed preparation of Propionibacterium acnes. Fifty-one lactating dairy cows with chronic S. aureus IMI on two commercial dairies were enrolled in a controlled, randomized field trial. Twenty-four cows received 1 ml of the immunostimulant twice weekly for 4 wk, and the remainder of the cows served as untreated controls. Quarter milk samples were collected for SCC from all cows at 3 and 6 wk after initiation of treatment and for culture at 6 wk after initiation of treatment. If samples were negative for S. aureus at 6 wk, cows were sampled again for culture 1 wk later for 2 successive d before being considered cured. For the cows treated with immunostimulant, 16.7% (36.7% of infected quarters) were cured of S. aureus IMI; for the untreated group, 11.1% of cows (32.2% of quarters) were cured. The difference was not statistically significant. Immunostimulant treatment had no effect on quarter SCC in infected quarters overall, but, in those quarters that were cured of S. aureus infection, quarter SCC of treated cows tended to be lower than SCC of control cows.

Genetic improvement of mastitis through selection on somatic cell count

Heredity influences both clinical mastitis and somatic cell score. Intramammary infection is the major cause of elevated somatic cell score. A nationwide program of genetic evaluation of dairy cattle for somatic cell score is being developed. Proper selection of artificial insemination sires, considering their genetic merit for both milk production and somatic cell score, will reduce the genetic increase in mastitis susceptibility that accompanies selection for high production.